MPM Oncology Impact Management »

Palvella Therapeutics Inc Ne shares owned by MPM Oncology Impact Management

Quarter-by-quarter ownership of Palvella Therapeutics Inc Ne (PVLA) shares owned by MPM Oncology Impact Management from 13F filings

Historical chart of MPM Oncology Impact Management investment in Palvella Therapeutics Inc Ne

Tip: Access up to 7 years of quarterly data

All positions including Palvella Therapeutics Inc Ne held by MPM Oncology Impact Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palvella Therapeutics Inc Ne by MPM Oncology Impact Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $22M 206k 104.67
2025-09-30 $4.2M 67k 62.69

More positions owned by MPM Oncology Impact Management

Cullinan Therapeutics Common (CGEM)
Madrigal Pharmaceuticals Common (MDGL)
Liquidia Corp Common (LQDA)
Trevi Therapeutics Common (TRVI)
Edgewise Therapeutics Common (EWTX)
Revolution Medicines Common (RVMD)
Agios Pharmaceuticals Common (AGIO)
Uniqure NV Common (QURE)
PTC Therapeutics Common (PTCT)
Syndax Pharmaceuticals Common (SNDX)
Dyne Therapeutics Common (DYN)
Tarsus Pharmaceuticals Common (TARS)
Stoke Therapeutics Common (STOK)
Alumis Common (ALMS)
Urogen Pharma Common (URGN)

View all positions for MPM Oncology Impact Management

Top funds holding Palvella Therapeutics Inc Ne

BVF
Suvretta Capital Management
Frazier Life Sciences Management
First Light Asset Management
Vanguard Group
BlackRock
State Street Corporation
Perceptive Advisors
Summit Partners Public Asset Management
Jennison Associates
Federated Investors
Woodline Partners
Artisan Partners Limited Partnership
MPM Oncology Impact Management
Caption Management

View all funds holding Palvella Therapeutics Inc Ne